Narcolepsy with Migraine: What to Do When Solriamfetol Has Not Controlled Excessive Daytime Sleepiness

Clinical Scenario

This protocol addresses patients with narcolepsy who also have migraine headache. In this population, narcolepsy can itself trigger migraines, and when managing both conditions simultaneously, the adverse effect of any treatment on either condition must be minimised.

Previous Treatment — Escalation Trigger

The preceding approach used solriamfetol, chosen for its relatively low headache incidence and absence of interaction with hormonal contraception. The target was reduction in excessive daytime sleepiness without increased headache frequency or severity. When that goal is not achieved, a structured next-line protocol applies.

Next-Line Approach (Overview)

Agents with a more favourable headache profile — specifically pitolisant and oxybates — are among the options considered at this stage. The complete selection criteria, sequencing, and structured regimen are available via the link below.

Treatment Goal

Reduction in excessive daytime sleepiness without increased headache.

Instant Access to Structured Evidence-Based Regimens

References

DOI: 10.9740/mhc.2025.12.258

In addition to EDS, narcolepsy can trigger migraines.

When managing a patient with coexisting narcolepsy and migraines, the negative effect of medications on either condition should be minimized.

According to clinical experience, headache is also less common with pitolisant and oxybates and could be considered if EDS persists on solriamfetol.

View source ↗